HOUSTON--(BUSINESS WIRE)--As the Public Health Emergency (PHE) expires, it’s evident how far we have come in providing care and treatment, yet there is still substantial work to be done. Qbtech, Inc., ...
Sweden-based Qbtech has received an FDA 510(k) clearance for an online tool, called QbCheck, that offers clinical decision-making support for diagnosing and treating children with ADHD. According to ...
HOUSTON, October 15, 2024--(BUSINESS WIRE)--Qbtech, the global leader in objective ADHD testing, today announced the launch of its new grant program, QbAccess. Created to make ADHD testing and care ...
LONDON & HOUSTON--(BUSINESS WIRE)--The Focus ADHD program, created by objective testing provider Qbtech and the AHSN Network, received the Best Innovative Mental Health Invention at the 2022 National ...
Addition of clinical research and strategic partnership teams marks another milestone for Qbtech in North America, bolstering the company’s regional capabilities and footprint HOUSTON, June 02, 2025-- ...
Texas office will serve as home base for U.S. operations, expanding the company's presence in the market and contributing to the local economy Qbtech, the global leader in objective ADHD testing, ...
Data presented at ADHD World Congress highlights how QbCheck supports diagnostic accuracy and individualized treatment monitoring, enabling efficient and robust care in virtual settings. News Summary: ...
Following Telehealth Company’s Fallout, Global Leader in Evidence-based Objective ADHD Testing Technology Seeks to Ease Diagnosis Concerns of Former Done Patients HOUSTON, July 15, 2024--(BUSINESS ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Thanks to growth from an equity ...
STOCKHOLM & HOUSTON–(BUSINESS WIRE)–Today, Qbtech announces a partnership in The Netherlands with one of the leading ADHD care providers, ADHDcentraal. The purpose of the collaboration is to create ...
In response to the recent arrests of Done founder Ruthia He and clinical leader David Brody for the company's alleged stimulant prescription practices, Qbtech, the global leader in objective ADHD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results